Transcription factors Sox10 and Sox2 functionally interact with positive transcription elongation factor b in Schwann cells

Journal of Neurochemistry

Volumn 132, Issue 4, 2015, Pages 384-393

  Arter, Juliane ^a   Wegner, Michael ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

glia; HMG; PTEF b; Schwann cells; Sox10; Sox2; Sry

Indexed keywords

CYCLIN T1; DNA; MYELIN; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX2; PROTEIN BINDING; SOX10 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MATURATION; CHROMATIN STRUCTURE; DNA CONFORMATION; HIGH MOBILITY GROUP BOX DOMAIN; HUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SCHWANN CELL; TRANSACTIVATION; TRANSCRIPTION ELONGATION; ANIMAL; GENETIC TRANSCRIPTION; HEK293 CELL LINE; METABOLISM; MOUSE; PHYSIOLOGY; RAT; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; MICE; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN BINDING; RATS; SCHWANN CELLS; SOXB1 TRANSCRIPTION FACTORS; SOXE TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84922644517     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.13013     Document Type: Article

References (35)

1. Barboric M., Nissen R. M., Kanazawa S., Jabrane-Ferrat N., and, Peterlin B. M., (2001) NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8, 327-337.
2. Bergsland M., Ramskold D., Zaouter C., Klum S., Sandberg R., and, Muhr J., (2011) Sequentially acting Sox transcription factors in neural lineage development. Genes Dev. 25, 2453-2464.
3. Bondurand N., Girard M., Pingault V., Lemort N., Dubourg O., and, Goossens M., (2001) Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum. Mol. Genet. 10, 2783-2795.
4. Eberhardy S. R., and, Farnham P. J., (2002) Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter. J. Biol. Chem. 277, 40156-40162.
5. Engelen E., Akinci U., Bryne J. C., et al,. (2011) Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nat. Genet. 43, 607-611.
6. Hoffmann S. A., Hos D., Küspert M., Lang R. A., Lovell-Badge R., Wegner M., and, Reiprich S., (2014) Stem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytes. Development 141, 39-50.
7. Jacob C., Christen C. N., Pereira J. A., et al,. (2011) HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells. Nat. Neurosci. 14, 429-436.
8. Kamachi Y., and, Kondoh H., (2013) Sox proteins: regulators of cell fate specification and differentiation. Development 140, 4129-4144.
9. Kanazawa S., Okamoto T., and, Peterlin B. M., (2000) Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity 12, 61-70.
10. Kellerer S., Schreiner S., Stolt C. C., Bösl M. R., and, Wegner M., (2006) Replacement of the Sox10 transcription factor by Sox8 reveals incomplete functional equivalence. Development 133, 2875-2886.
11. Kim S., Kim J. D., Chung A. Y., et al,. (2012) Antagonistic regulation of PAF1C and p-TEFb is required for oligodendrocyte differentiation. J. Neurosci. 32, 8201-8207.
12. Kuhlbrodt K., Herbarth B., Sock E., Hermans-Borgmeyer I., and, Wegner M., (1998) Sox10, a novel transcriptional modulator in glial cells. J. Neurosci. 18, 237-250.
13. Le N., Nagarajan R., Wang J. Y., Araki T., Schmidt R. E., and, Milbrandt J., (2005) Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. Natl Acad. Sci. USA 102, 2596-2601.
14. Li Q., Price J. P., Byers S. A., Cheng D., Peng J., and, Price D. H., (2005) Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules containing Cdk9 phosphorylated at threonine 186. J. Biol. Chem. 280, 28819-28826.
15. Maka M., Stolt C. C., and, Wegner M., (2005) Identification of Sox8 as a modifier gene in a mouse model of Hirschsprung disease reveals underlying molecular defect. Dev. Biol. 277, 155-169.
16. Mueller D., Garcia-Cuellar M. P., Bach C., Buhl S., Maethner E., and, Slany R. K., (2009) Misguided transcriptional elongation causes mixed lineage leukemia. PLoS Biol. 7, e1000249.
17. Nakamura Y., Yamamoto K., He X., et al,. (2011) Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat. Commun. 2, 251.
18. Oven I., Brdickova N., Kohoutek J., Vaupotic T., Narat M., and, Peterlin B. M., (2007) AIRE recruits P-TEFb for transcriptional elongation of target genes in medullary thymic epithelial cells. Mol. Cell. Biol. 27, 8815-8823.
19. Peirano R. I., Goerich D. E., Riethmacher D., and, Wegner M., (2000) Protein zero expression is regulated by the glial transcription factor Sox10. Mol. Cell. Biol. 20, 3198-3209.
20. Rahl P. B., Lin C. Y., Seila A. C., Flynn R. A., McCuine S., Burge C. B., Sharp P. A., and, Young R. A., (2010) c-Myc regulates transcriptional pause release. Cell 141, 432-445.
21. Rau M. J., Fischer S., and, Neumann C. J., (2006) Zebrafish Trap230/Med12 is required as a coactivator for Sox9-dependent neural crest, cartilage and ear development. Dev. Biol. 296, 83-93.
22. Schlierf B., Ludwig A., Klenovsek K., and, Wegner M., (2002) Cooperative binding of Sox10 to DNA: requirements and consequences. Nucleic Acids Res. 30, 5509-5516.
23. Stolt C. C., and, Wegner M., (2010) SoxE function in vertebrate nervous system development. Int. J. Biochem. Cell Biol. 42, 437-440.
24. Stolt C. C., Rehberg S., Ader M., Lommes P., Riethmacher D., Schachner M., Bartsch U., and, Wegner M., (2002) Terminal differentiation of myelin-forming oligodendrocytes depends on the transcription factor Sox10. Genes Dev. 16, 165-170.
25. Stolt C. C., Lommes P., Sock E., Chaboissier M.-C., Schedl A., and, Wegner M., (2003) The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 17, 1677-1689.
26. Stolt C. C., Lommes P., Friedrich R. P., and, Wegner M., (2004) Transcription factors Sox8 and Sox10 perform non-equivalent roles during oligodendrocyte development despite functional redundancy. Development 131, 2349-2358.
27. Thein D. C., Thalhammer J. M., Hartwig A. C., Crenshaw E. B., 3rd, Lefebvre V., Wegner M., and, Sock E., (2010) The closely related transcription factors Sox4 and Sox11 function as survival factors during spinal cord development. J. Neurochem. 115, 131-141.
28. Vogl M. R., Reiprich S., Kuspert M., Kosian T., Schrewe H., Nave K. A., and, Wegner M., (2013) Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia. J. Neurosci. 33, 6679-6690.
29. Wahlbuhl M., Reiprich S., Vogl M. R., Bosl M. R., and, Wegner M., (2011) Transcription factor Sox10 orchestrates activity of a neural crest-specific enhancer in the vicinity of its gene. Nucleic Acids Res. 40, 88-101.
30. Wegner M., (2010) All purpose Sox: the many roles of Sox proteins in gene expression. Int. J. Biochem. Cell Biol. 42, 381-390.
31. Weider M., Küspert M., Bischof M., et al,. (2012) Chromatin-remodeling factor Brg1 is required for Schwann cell differentiation and myelination. Dev. Cell 23, 193-201.
32. Weider M., Reiprich S., and, Wegner M., (2013) Sox appeal-Sox10 attracts epigenetic and transcriptional regulators in myelinating glia. Biol. Chem. 394, 1583-1593.
33. Wißmüller S., Kosian T., Wolf M., Finzsch M., and, Wegner M., (2006) The High-mobility-group domain of Sox proteins interacts with the DNA-binding domains of many transcription factors. Nucleic Acids Res. 34, 1735-1744.
34. Yamaguchi Y., Shibata H., and, Handa H., (2013) Transcription elongation factors DSIF and NELF: promoter-proximal pausing and beyond. Biochim. Biophys. Acta 1829, 98-104.
35. Zhou Q., Li T., and, Price D. H., (2012) RNA polymerase II elongation control. Annu. Rev. Biochem. 81, 119-143.